Assenagon Asset Management S.A. Ocular Therapeutix, Inc Transaction History
Assenagon Asset Management S.A.
- $60.5 Billion
- Q2 2025
A detailed history of Assenagon Asset Management S.A. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 193,700 shares of OCUL stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
193,700
Previous 341,800
43.33%
Holding current value
$2.24 Million
Previous $2.51 Million
28.26%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding OCUL
# of Institutions
206Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$165 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$160 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$147 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$133 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$96.6 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $889M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...